Samrat Pharmachem Share Price

Samrat Pharmachem Ltd. key Products/Revenue Segments include Chemicals (Pharmaceutical) for the year ending 31-Mar-2025.

For the quarter ended 31-03-2026, the company has reported a Standalone Total Income of Rs 71.47 Crore, up 11.97 % from last quarter Total Income of Rs 63.83 Crore and up .52 % from last year same quarter Total Income of Rs 71.10 Crore. Company has reported net profit after tax of Rs -2.04 Crore in latest quarter.

The company’s top management includes Mr.Lalit Mehta, Mr.Rajesh Mehta, Mr.Megh Mehta, Mr.Manishkumar Pipalia, Ms.Megha Jain, Ms.Renu Dharod, Mr.Sachin Kothary, Mr.Nishant Kankaria. Company has Shah & Savla LLP as its auditors. As on 31-03-2026, the company has a total of .31 Crore shares outstanding.

Samrat Pharma Share Price Today is Rs. 198.75. On previous day, the Samrat Pharma Share Price (NSE) closed at Rs. 198.3, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 49.09% of the stake in Samrat Pharma shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of Samrat Pharma stocks was 3.24% as compared to 3.24% in Dec 2025 with decrease of 0.0%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 0.0% as compared to 0.0% in Dec 2025 with null of 0.0%. Out of the total DII holdings in Samrat Pharma shares 0.0% was held by mutual funds. The rest including public held is 0.0%. Samrat Pharma stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
Samrat Pharma Dividend: Ever since 1992, Samrat Pharma dividends has been paid out around 6 times. As on 19 Jun, 2026, 03:40 PM IST, The overall dividend yield for Samrat Pharma stands at 0.0%. The last dividend paid was on September 18, 2025 (Rs. 1.0). The Earnings Per Share (EPS) for quarter ending 31st Mar 2026 is Rs. -10.72.

Samrat Pharma Bonus: The most recent bonus issue had been in year null around 0 years ago at 0 : 0 ratio. The first bonus issue was announced in null.

Stock Forecast:
After showing 71.47 Cr. of sales and 11.97% of quarterly net profit, there have been multiple ups and downs in the Samrat Pharma stock prices in the past few weeks. For example, Samrat Pharma stock price on 11th of June 2026 was around Rs. 200.15. Samrat Pharma share price now stands at an average of Rs. 198.75. Judging by last week's performance, stock is in down trend.

Samrat Pharma has a median target price of Rs. 0.0 in 12 months by 0 analysts. They have provided a high estimate of Rs. 0.0 and low estimate of Rs. 0.0 for Samrat Pharma share.

Historical Prices and Performance:
Samrat Pharma, incorporated in 1992 is a Small Cap company (with a market cap of Rs. 60.76) operating in Pharmaceuticals sector.
The Return of Equity (ROE) in last five financial years given by Samrat Pharma stock was -4.85%, 9.9%, 3.32%, 26.33% and 36.7% respectively.
The Samrat Pharma share gave a 3 year return of -55.04% as compared to Nifty 50 which gave a return of 28.38%.
Samrat Pharma announced 10.0% final dividend on September 18, 2025.

Key Metrics:
PE Ratio of Samrat Pharma is -18.5
Prices/Sales Ratio of Samrat Pharma is 0.21
Price/Book Ratio of Samrat Pharma is 0.9

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. The PE ratio and PB Ratio of the company are among its competitors stand at -18.5 and 0.9 respectively.

Leadership of Samrat Pharma :
Nishant Kankaria is Co. Secretary & Compl. Officer
Lalit Mehta is Chairman & Managing Director
Rajesh Mehta is Executive Director & CFO
Megh Mehta is Executive Director
Renu Dharod is Ind. Non-Executive Director
Manishkumar Pipalia is Ind. Non-Executive Director
Sachin Kothary is Ind. Non-Executive Director
Megha Jain is Ind. Non-Executive Director